A British baby’s death this year after getting Novartis’s gene therapy Zolgensma was not caused by a toxic drug reaction, the Swiss drugmaker said, allaying concerns over the $2.1 million-per-patient treatment’s risks.
An independent expert panel to the U.S. Food and Drug Administration on Wednesday recommended approval of GlaxoSmithKline Plc’s over-the-counter nicotine oral spray that aims to help smokers quit their addiction.
For two men trained as scientists, the bosses of Britain’s major insulin providers have had to become experts in ferry schedules, trucking laws and warehouse capacity as they seek to guarantee the supply of life-saving drugs through a chaotic Brexit.
With Britain sourcing the vast majority of the insulin needed by its 1 million diabetics from overseas, its biggest providers have had to restructure their supply chains in case a chaotic Brexit disrupts the normal arteries of trade.
CEO of Seeker Health, a digital health company innovating that way that patients connect to clinical trials. Using technology and social media, Seeker Health helps medicines get developed faster and reach those who need them earlier. Seeker Health specializes in accelerating global clinical trials in serious diseases with hard-to-find patient populations, including oncology and rare diseases. For more information visit www.seekerhealth.com. Connect with Sandra Shpilberg on LinkedIn https://www.linkedin.com/in/sandra-shpilberg-b7b334/